top of page
Consortium_2.jpg

Youth Mental Wellness and Resiliency Special Interest Group (SIG)

The Youth Mental Wellness and Resiliency Special Interest Group (SIG) brings together clinical leaders, researchers, and youth-focused professionals committed to advancing pediatric mental wellness through immersive technology.

This collaborative group is dedicated to sharing best practices, exploring emerging research, and co-developing strategies that help young people build emotional regulation, manage stress, and strengthen resilience in both medical and community settings.

The SIG reflects Invincikids’ commitment to safe, effective, and accessible immersive tools that address the mental and emotional needs of children worldwide. By integrating mindfulness, cognitive behavioral strategies, and engaging virtual environments, the group works to ensure that all children—regardless of geography or resources—can access meaningful mental wellness support.

Members of the SIG will play a central role in shaping clinical workflows, informing content development, and supporting equitable distribution so these tools reach the children who need them most.

Sign up to follow and engage with the Youth Wellness and Resiliency SIG

We invite all those interested in the important work of this group to join and follow our progress.  We will also be hosting events in the future to highlight research, software development, and send out periodic newsletters. 

Invincikids

Palo Alto, California

Andre@invincikids.org

  • Facebook
  • Twitter

About us

Partner with us

Donate and contribute

Interested in working with Invincikids?

© 2024 Invincikids

None of the products discussed on this Site have been authorized by any regulatory authority for commercial use in any medical or clinical applications in any jurisdiction. Use of virtual reality and immersive technology hardware and software consumer products in clinical applications, such as pain management, has only been evaluated in research studies, which means safety and performance of these consumer products for clinical or medical indications have not been fully validated, reviewed, cleared or approved by any regulatory authority.

Terms of Use.  Privacy Policy

bottom of page